BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 32545484)

  • 21. α-Lipoic Acid Has the Potential to Normalize Copper Metabolism, Which Is Dysregulated in Alzheimer's Disease.
    Metsla K; Kirss S; Laks K; Sildnik G; Palgi M; Palumaa T; Tõugu V; Palumaa P
    J Alzheimers Dis; 2022; 85(2):715-728. PubMed ID: 34864665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Copper transport and Alzheimer's disease.
    Macreadie IG
    Eur Biophys J; 2008 Mar; 37(3):295-300. PubMed ID: 18004558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered microglial copper homeostasis in a mouse model of Alzheimer's disease.
    Zheng Z; White C; Lee J; Peterson TS; Bush AI; Sun GY; Weisman GA; Petris MJ
    J Neurochem; 2010 Sep; 114(6):1630-8. PubMed ID: 20626553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards a unified vision of copper involvement in Alzheimer's disease: a review connecting basic, experimental, and clinical research.
    Pal A; Siotto M; Prasad R; Squitti R
    J Alzheimers Dis; 2015; 44(2):343-54. PubMed ID: 25261447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agents complexing copper as a therapeutic strategy for the treatment of Alzheimer's disease.
    Squitti R; Salustri C
    Curr Alzheimer Res; 2009 Dec; 6(6):476-87. PubMed ID: 19747159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Copper-mediated β-amyloid toxicity and its chelation therapy in Alzheimer's disease.
    Singh SK; Balendra V; Obaid AA; Esposto J; Tikhonova MA; Gautam NK; Poeggeler B
    Metallomics; 2022 Jun; 14(6):. PubMed ID: 35333348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ESSIMAGE: a tool for the assessment of the agroecological performance of agricultural production systems.
    Trabelsi M; Mandart E; Le Grusse P; Bord JP
    Environ Sci Pollut Res Int; 2019 Mar; 26(9):9257-9280. PubMed ID: 30721436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Copper Imbalance in Alzheimer's Disease and Its Link with the Amyloid Hypothesis: Towards a Combined Clinical, Chemical, and Genetic Etiology.
    Squitti R; Faller P; Hureau C; Granzotto A; White AR; Kepp KP
    J Alzheimers Dis; 2021; 83(1):23-41. PubMed ID: 34219710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain biometals and Alzheimer's disease - boon or bane?
    Prakash A; Dhaliwal GK; Kumar P; Majeed AB
    Int J Neurosci; 2017 Feb; 127(2):99-108. PubMed ID: 27044501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of copper and iron homeostasis by metal chelators: a possible chemotherapy for Alzheimer's disease.
    Robert A; Liu Y; Nguyen M; Meunier B
    Acc Chem Res; 2015 May; 48(5):1332-9. PubMed ID: 25946460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The essential elements of Alzheimer's disease.
    Lei P; Ayton S; Bush AI
    J Biol Chem; 2021; 296():100105. PubMed ID: 33219130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is brain copper deficiency in Alzheimer's, Lewy body, and Creutzfeldt Jakob diseases the common key for a free radical mechanism and oxidative stress-induced damage?
    Deloncle R; Guillard O
    J Alzheimers Dis; 2015; 43(4):1149-56. PubMed ID: 25125459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metal Toxicity Links to Alzheimer's Disease and Neuroinflammation.
    Huat TJ; Camats-Perna J; Newcombe EA; Valmas N; Kitazawa M; Medeiros R
    J Mol Biol; 2019 Apr; 431(9):1843-1868. PubMed ID: 30664867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholesterol, copper, and accumulation of thioflavine S-reactive Alzheimer's-like amyloid beta in rabbit brain.
    Larry Sparks D
    J Mol Neurosci; 2004; 24(1):97-104. PubMed ID: 15314257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Copper in disorders with neurological symptoms: Alzheimer's, Menkes, and Wilson diseases.
    Strausak D; Mercer JF; Dieter HH; Stremmel W; Multhaup G
    Brain Res Bull; 2001 May; 55(2):175-85. PubMed ID: 11470313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zinc takes the center stage: its paradoxical role in Alzheimer's disease.
    Cuajungco MP; Fagét KY
    Brain Res Brain Res Rev; 2003 Jan; 41(1):44-56. PubMed ID: 12505647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alzheimer's disease, metal ions and metal homeostatic therapy.
    Zatta P; Drago D; Bolognin S; Sensi SL
    Trends Pharmacol Sci; 2009 Jul; 30(7):346-55. PubMed ID: 19540003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is There a Connection between the Metabolism of Copper, Sulfur, and Molybdenum in Alzheimer's Disease? New Insights on Disease Etiology.
    Coelho FC; Cerchiaro G; Araújo SES; Daher JPL; Cardoso SA; Coelho GF; Guimarães AG
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of aging on copper isotopic composition in the murine brain.
    Lahoud E; Moynier F; Luu TH; Mahan B; Borgne ML
    Metallomics; 2024 May; 16(5):. PubMed ID: 38289854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Copper dysfunction in Alzheimer's disease: from meta-analysis of biochemical studies to new insight into genetics.
    Squitti R
    J Trace Elem Med Biol; 2012 Jun; 26(2-3):93-6. PubMed ID: 22565015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.